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BACKGROUND
The narrow host range of Mycobacterium leprae and the fact that it is refractory to 
growth in culture has limited research on and the biologic understanding of lep-
rosy. Host genetic factors are thought to influence susceptibility to infection as well 
as disease progression.
METHODS
We performed a two-stage genomewide association study by genotyping 706 pa-
tients and 1225 controls using the Human610-Quad BeadChip (Illumina). We then 
tested three independent replication sets for an association between the presence 
of leprosy and 93 single-nucleotide polymorphisms (SNPs) that were most strongly 
associated with the disease in the genomewide association study. Together, these 
replication sets comprised 3254 patients and 5955 controls. We also carried out tests 
of heterogeneity of the associations (or lack thereof) between these 93 SNPs and 
disease, stratified according to clinical subtype (multibacillary vs. paucibacillary).
RESULTS
We observed a significant association (P<1.00×10−10) between SNPs in the genes 
CCDC122, C13orf31, NOD2, TNFSF15, HLA-DR, and RIPK2 and a trend toward an as-
sociation (P = 5.10×10−5) with a SNP in LRRK2. The associations between the SNPs 
in C13orf31, LRRK2, NOD2, and RIPK2 and multibacillary leprosy were stronger than 
the associations between these SNPs and paucibacillary leprosy.
CONCLUSIONS
Variants of genes in the NOD2-mediated signaling pathway (which regulates the in-
nate immune response) are associated with susceptibility to infection with M. leprae.
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Leprosy is a chronic infectious dis-ease caused by Mycobacterium leprae. It affects the skin and peripheral nerves and can cause 
irreversible impairment of nerve function and con-
sequent chronic disabilities.1 Despite a dramatic 
decrease in its prevalence over the past two de-
cades (largely due to the worldwide introduction 
of multidrug therapy in 1982),2 leprosy remains a 
major public health problem and one of the most 
important preventable disabilities in many devel-
oping countries.3 It is therefore particularly unfor-
tunate that research into the mechanisms under-
lying infection and clinical sequelae has been 
limited by the fact that M. leprae infects only hu-
mans and cannot be cultured in vitro.4
The clinical disease of leprosy develops in a 
minority of infected persons,5 and it manifests as 
a spectrum of disease symptoms that result from 
interactions between the host’s immune response 
and the bacterium. Tuberculoid and lepromatous 
leprosy are at opposite ends of the spectrum, each 
being associated with a relatively stable immune 
status of the host. “Borderline” categories of the 
disease, characterized by a variety of clinical 
manifestations, are associated with an unstable 
immune response to the bacilli.6
The unusually low diversity of genomic se-
quences among M. leprae strains makes it unlikely 
that differences in susceptibility or clinical mani-
festation are governed by the strain of M. leprae 
or variation within each strain.7 Therefore, the 
immunologic response of the host is thought to 
play a critical role; multibacillary infection is as-
sociated with a type 2 helper T (Th2) cell re-
sponse, whereas paucibacillary infection is asso-
ciated with an immune response mediated by 
type 1 helper T (Th1) cells.8
Host genetic factors have been implicated in 
susceptibility to leprosy in studies of familial clus-
tering, studies of twins, complex segregation 
analyses, and tests of association with the HLA 
genes.9-13 Markers in several genes and genomic 
regions (e.g., HLA-DR [the gene encoding major 
histocompatibility complex class II DR], PARK2–
PACRG [genes encoding proteins related to Parkin-
son’s disease], LTA [the gene encoding lympho-
toxin alpha], and chromosome 10p13) have been 
reported to be associated with susceptibility to 
leprosy or the development of a particular clinical 
form of the disease, but few of these associations 
have been replicated.14-17 We performed a genome-
wide association study involving large numbers 
of patients with leprosy and unaffected persons 
(controls).
Me thods
We carried out a genomewide association study of 
leprosy in a “discovery” set of 706 affected patients 
and 1225 unaffected controls, all of whom were 
Han Chinese from eastern China. The first repli-
cation set consisted of Han Chinese from eastern 
China, and the second and third replication sets 
were made up of Han Chinese as well as persons 
from minority, non-Han ethnic groups (including 
the Chung, Miao, Yízú, and other smaller groups) 
from southern China.
Leprosy was diagnosed on the basis of consen-
sus by at least two dermatologists. From medical 
records, we determined the clinical subtype of the 
disease, whether there was a family history of lep-
rosy, and the age at onset of disease. The controls 
did not have a history of leprosy, autoimmune, or 
systemic disorders or a family history of leprosy 
(among first-, second-, or third-degree relatives). 
Patients and controls self-reported their age, sex, 
and ethnic group on a questionnaire. All partici-
pants reported that they were free of infection by 
M. tuberculosis and chronic infection by other agents 
(with the exception of M. leprae in the case pa-
tients). Patients and controls were matched accord-
ing to ethnic origin and geographic region of 
recruitment. All participants provided written in-
formed consent, and the study was approved by 
local institutional ethics committees (see the Sup-
plementary Appendix, available with the full text 
of this article at NEJM.org).
We carried out the genomewide association 
study using Human610-Quad BeadChip (Illumina) 
and the follow-up genotyping using the iPLEX 
system (Sequenom) and the TaqMan assay (Ap-
plied Biosystems). We tested for population strat-
ification in the discovery set using a method based 
on principal-components analysis and tested for 
the presence of genotype–phenotype associations 
using the Cochran–Armitage trend test with and 
without correction for population stratification. 
We also carried out heterogeneity analyses of the 
93 single-nucleotide polymorphisms (SNPs) with 
the strongest associations with disease suscepti-
bility in the genomewide association study to de-
termine whether these associations were dispro-
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portionately driven by the presence or absence of 
family history of leprosy, presence or absence of 
disability from leprosy, the age at onset of the 
disease, or its clinical subtype. More information 
on the samples, genotyping, quality control, and 
statistical analyses is provided in the Supplemen-
tary Appendix.
R esult s
Genomewide Association Analysis
After filtering the data obtained by genomewide 
association study, for purposes of quality control, 
a total of 491,883 SNPs from 706 case patients and 
1225 controls remained and were subjected to sta-
tistical analysis (see the Supplementary Appendix). 
Principal-components analysis, using the 206 
HapMap reference samples, confirmed that all par-
ticipants were of Chinese ancestry (Fig. 1 in the 
Supplementary Appendix), although the case pa-
tients and controls showed some genetic stratifi-
cation (Fig. 2 in the Supplementary Appendix). 
To minimize the effect of population stratifica-
tion, we tested for the presence of genotype–phe-
notype associations using two approaches. First, 
we analyzed the genomewide genotypes of the 
706 case patients and 1225 controls using the 
Cochran–Armitage trend test with correction for 
population stratification based on principal-com-
ponents analysis.18 Second, we tested the geno-
types for an association with affected status, with-
out correction for population stratification, after 
removing the 711 genetically unmatched controls 
(Fig. 3 in the Supplementary Appendix). (The sum-
mary statistics of the full data set obtained by 
means of the genomewide association analysis can 
be obtained from the National Center for Biotech-
nology Information’s database of genotypes and 
phenotypes [dbGaP; www.ncbi.nlm.nih.gov/gap], 
accession number phs000217.v1.p1.)
The results of these two analyses indicated that 
there was no overall inflation of the associations 
with leprosy because of population stratification 
(Fig. 4 in the Supplementary Appendix). Moreover, 
the results of the two analyses were generally con-
sistent, suggesting a strong association within the 
major histocompatibility complex (MHC) region 
(on chromosome 6p21) and additional associations 
at chromosome 16q12 (rs9302752; P = 1.42×10−9; 
odds ratio for leprosy, 2.28) and chromosome 
13q14 (rs3764147; P = 4.06×10−7; odds ratio, 1.97) 
(Fig. 1 and Table 1). The P values yielded by both 
analyses showed a deviation from the null distri-
bution of no association after the SNPs within 
the MHC region were removed from the analyses, 
suggesting that the observed P values within the 
tail of the distribution are smaller than those ex-
pected on the basis of chance and therefore prob-
ably reflect true genetic associations (Fig. 4 in the 
Supplementary Appendix).
We observed two associations with leprosy 
within the MHC region. One was within the HLA-
B–HLA-C locus (encoding MHC, classes I, B and C), 
at which the most strongly associated SNP was 
rs9264868 (P = 1.96×10−4; odds ratio, 2.12), and 
the other was within the HLA-DR–DQ locus (en-
coding MHC, class II, DR and DQ), at which 
the most strongly associated SNP was rs9271366 
(P = 1.94×10−17; odds ratio, 2.35) (Fig. 5 in the 
Supplementary Appendix). After controlling for 
the genetic effect of rs9271366, the association 
within the HLA-B–HLA-C locus remained signifi-
cant (Table 2 in the Supplementary Appendix), 
suggesting that these two associations are inde-
pendent of each other.
Tests of Replication
We genotyped 93 SNPs — those that showed the 
strongest association with leprosy in the genome-
wide association study — in samples from three 
replication sets: two consisting of Han Chinese 
and one of Chinese minority groups — collective-
ly, 3254 case patients and 5955 controls (Table 1). 
In addition to these tests of association carried out 
using each of the three replication sets, we carried 
out a combined analysis of the results obtained 
by means of targeted genotyping of the samples 
in the replication sets and the genomewide geno-
typing of the samples in the discovery set. (With 
respect to the discovery set, we used results from 
the second analysis, in which we used the small-
er group of matched control samples.)
With respect to evaluating the MHC region in 
the replication sets, we genotyped two SNPs: 
rs602875 at the HLA-DR–DQ locus (P = 3.47×10−4; 
odds ratio, 0.58) (since rs9271366, also at this lo-
cus and with a stronger association, was refrac-
tory to genotyping) and rs9264868 at the HLA-B–
C locus (P = 1.96×10−4; odds ratio, 2.12) (Fig. 5 in 
the Supplementary Appendix). The results of the 
combined analysis strongly support an association 
between rs602875 and susceptibility to leprosy 
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Figure 1. Results of Genomewide Association Analysis.
The −log10 genomewide P values, as calculated with the use of the Cochran–Armitage trend test, are shown. Panel A 
shows the P values, after EIGENSTRAT correction, calculated on the basis of data from 491,883 polymorphic single-
nucleotide polymorphisms (SNPs) identified in the 706 patients with leprosy and 1225 controls (total, 1931 sam-
ples). Panel B shows the P values calculated on the basis of data from 492,109 polymorphic SNPs in the 706 pa-
tients and the 514 genetically matched controls (total, 1220 samples). The red horizontal lines indicate 
P = 1.00×10−5, the threshold used for a trend toward genomewide significance.
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(P = 5.33×10−27; odds ratio, 0.67) but not between 
rs9264868 and the disease (P = 2.33×10−3; odds ra-
tio, 1.14).
The associations with susceptibility to disease 
were replicated for two SNPs (rs42490 and rs40457) 
within RIPK2 (the gene encoding receptor-inter-
acting serine–threonine kinase 2, on chromosome 
8q21), three SNPs (rs4574921, rs10114470, and 
rs6478108) within TNFSF15 (the gene encoding 
tumor necrosis factor [ligand] superfamily mem-
ber 15, on chromosome 9q32), two SNPs (rs3764147 
and rs10507522) within C13orf31 (the gene en-
coding chromosome 13 open reading frame 31, 
on chromosome 13q14), two SNPs (rs9533634 and 
rs3088362) within CCDC122 (the gene encoding 
coiled-coil domain containing 122, on chromo-
some 13q14), and two SNPs (rs9302752 and 
rs7194886) within NOD2 (the gene encoding nu-
cleotide-binding oligomerization domain contain-
ing 2, on chromosome 16q12) (Table 2). At least 
two SNPs in each of these five genes showed sig-
nificant association (P<1.00×10−10 for all analy-
ses combined) with affected status. To investigate 
the independence of the multiple associations ob-
served within each of the five genes, we performed 
conditional association analyses, in which the ge-
netic effect of the most strongly associated SNP 
at each locus was controlled. These analyses re-
vealed at least two independently associated SNPs, 
located in different blocks of linkage disequilib-
Table 1. Baseline Characteristics of the Case Patients and Controls, According to Cohort.*
Characteristic
Genomewide 
Association Study
Replication 
Study 1
Replication 
Study 2
Replication 
Study 3 Total
Case patients
No. 706 2164 304 786 3960
Mean age (yr) 65.5 66.5 58.7 54.9 62.8
Mean age at onset of leprosy (yr) 21.8 21.4 26.5 26.2 23.3
Sex (no.)
Male 562 1742 221 535 3060
Female 144 422 83 251 900
Clinical subtype of leprosy (no.)†
Multibacillary 305 918 166 379 1768
Paucibacillary 397 1081 124 357 1959
Disabled from leprosy (no.)‡
Yes 570 947 149 353 2019
No 90 654 150 340 1234
Family history of leprosy (no.)§
Familial 185 165 62 80 492
Sporadic 521 1799 193 574 3087
Controls
No. 1225 4373 709 873 7180
Mean age (yr) 34.9 63.0 40.4 43.9 48.0
Sex (no.)
Male 670 2913 300 590 4473
Female 555 1460 409 283 2707
* Samples for the genomewide association study and replication study 1 were collected from Han Chinese in Shandong, 
Anhui, and Jiangsu provinces, eastern China; samples for replication study 2, from Han Chinese in Yunnan province, 
southern China; and samples for the replication study 3, from the Chung, Miao, Yizú, and other smaller minority groups 
in Yunnan province, southern China.
† Data on clinical subtype were missing for 233 patients.
‡ Data on disability status were missing for 707 patients.
§ Data on family history of leprosy were missing for 381 patients.
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rium (Table 2 in the Supplementary Appendix) and 
with low pairwise r2 values (<0.3) at each locus 
(Fig. 6 in the Supplementary Appendix).
The results indicate a trend toward an asso-
ciation between the SNP rs1873613 in LRRK2 (the 
gene encoding leucine-rich repeat kinase 2, on 
chromosome 12q12) and susceptibility to leprosy 
(Table 2). Inclusion of the replication samples 
strengthened the evidence for an association for 
this SNP (P = 5.10×10−5 for all analyses combined; 
odds ratio, 0.86). Joint analysis of the 1931 sam-
ples (including the 711 unmatched controls) in the 
genomewide association study and those in all 
three replication sets also supported an association 
(P = 3.68×10−5; odds ratio, 0.86), with an even 
stronger association from joint analysis of all the 
Han samples (from 3174 case patients and 6307 
controls) (P = 5.68×10−6; odds ratio, 0.82).
The results for the other 77 SNPs included in 
the replication analyses are summarized in Ta-
ble 1 in the Supplementary Appendix.
Analysis of Subgroups of Patients
The subgroup analysis of the multibacillary and 
paucibacillary clinical subtypes of leprosy revealed 
significant evidence for heterogeneity at five SNPs 
(rs3764147, rs10507522, rs9302752, rs42490, and 
rs1491938) within four genes (C13orf31, LRRK2, 
NOD2, and RIPK2). The associations of these SNPs 
were stronger with the multibacillary form of lep-
rosy than with the paucibacillary form, and the 
difference in the strength of association was sig-
nificant (defined as P<0.05 after correction for 
multiple testing for the 16 SNPs listed in Table 2) 
(Table 3). The rs1491938 variant (in LRRK2) showed 
a significant association with the multibacillary 
form (P = 2.26×10−6; odds ratio, 0.81) but not the 
paucibacillary form (P = 2.96×10−1; odds ratio, 0.96). 
Table 2. Associations with Leprosy for 16 Single-Nucleotide Polymorphisms (SNPs) within the Seven Susceptibility Genes, According to Analysis.*
SNP Chromosome Position
Major Allele/ 
Minor Allele Gene
Minor-Allele  
Frequency† Genomewide Association Study
P Value
Odds Ratio  
(95% CI)
rs602875 6 32681607 A/G HLA-DR–DQ 0.32 3.47×10−4 0.58 (0.43–0.79)
rs42490 8 90847650 G/A RIPK2 0.42 1.23×10−3 0.66 (0.51–0.87)
rs40457 8 90892832 A/G RIPK2 0.28 1.43×10−2 0.73 (0.53–0.99)
rs10982385 9 116532838 A/C TNFSF15 0.44 6.09×10−2 1.28 (0.98–1.68)
rs4574921 9 116578155 A/G TNFSF15 0.32 2.38×10−3 1.46 (1.10–1.94)
rs10114470 9 116587593 A/G TNFSF15 0.47 1.47×10−4 1.60 (1.22–2.10)
rs6478108 9 116598524 G/A TNFSF15 0.46 4.55×10−4 1.54 (1.18–2.01)
rs1873613 12 38838684 A/G LRRK2 0.25 9.37×10−3 0.67 (0.49–0.91)
rs9533634 13 43295815 A/G CCDC122 0.24 1.43×10−1 0.85 (0.62–1.17)
rs3088362 13 43331630 C/A CCDC122 0.26 2.00×10−6 1.87 (1.38–2.53)
rs3764147 13 43355925 A/G C13orf31 0.31 4.06×10−7 1.97 (1.49–2.62)
rs10507522 13 43377000 A/G C13orf31 0.31 4.17×10−5 0.55 (0.40–0.75)
rs9302752 16 49276604 A/G NOD2 0.29 1.42×10−9 2.28 (1.70–3.06)
rs7194886 16 49282694 G/A NOD2 0.14 4.43×10−7 2.25 (1.58–3.21)
rs8057341 16 49295481 A/G NOD2 0.22 5.22×10−2 1.33 (0.96–1.84)
rs3135499 16 49323628 A/C NOD2 0.21 9.21×10−2 1.26 (0.91–1.74)
* The odds ratios for leprosy and P values were calculated with the use of the Cochran–Armitage trend test. The P values were calculated after 
adjustment for age and sex. C13orf31 denotes the gene encoding chromosome 13 open reading frame 31, CCDC122 the gene encoding 
coiled-coil domain containing 122, CI confidence interval, HLA-DR the gene encoding major histocompatibility complex class II DR, LRRK2 
the gene encoding leucine-rich repeat kinase 2, NOD2 the gene encoding nucleotide-binding oligomerization domain containing 2, RIPK2 
the gene encoding receptor-interacting serine–threonine kinase 2, and TNFSF15 the gene encoding tumor necrosis factor (ligand) super-
family member 15.
† The minor-allele frequency is based on the controls.
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We did not detect effects of heterogeneity in other 
subgroups of patients (data not shown).
Pathway Analysis
We explored possible functional relationships be-
tween the seven identified susceptibility genes us-
ing the Ingenuity Pathways Analysis knowledge 
database (Ingenuity Systems). A single network of 
35 genes, including 5 of the 7 susceptibility genes, 
was identified through unsupervised network anal-
ysis, resulting in a highly significant score (one-
sided P = 1.00×10−15 by Fisher’s exact test). Figure 2 
illustrates the functional relationship between the 
five susceptibility genes (together with five other 
genes), creating a plausible biologic network un-
derlying susceptibility to leprosy.
Discussion
Through a genomewide association study of sus-
ceptibility to leprosy, we have implicated genetic 
variants in six genes that show a significant as-
sociation with disease and a seventh gene that 
shows a trend toward an association with disease. 
The controls, particularly the 1225 with samples 
analyzed in the genomewide association study, 
were younger than the case patients. It is possible 
that the controls were too young for the disease 
to have developed clinically but the effect of their 
comparative age on the strength of the associa-
tions is probably minimal, given the low incidence 
of leprosy in the general population.
The genomewide association study showed 
that, of the four SNPs at the NOD2 locus associated 
with leprosy, two SNPs (rs9302752 and rs7194886) 
lie between NOD2 and its 5′ neighboring gene, 
SNX20 (which encodes the sorting nexin 20 pro-
tein); these two intergenic SNPs are more strongly 
associated with leprosy than the two linked SNPs 
located within NOD2. We believe that the associa-
tions of leprosy with rs9302752 and rs7194886 
probably reflect the effects of regulatory variants 
on NOD2 expression.
All the implicated gene variants, with the pos-
sible exception of those of LRRK2, seem to con-
fer susceptibility to both multibacillary and pauc-
ibacillary forms of leprosy, indicating shared 
mechanisms underlying the development of these 
two clinical forms of the disease. However, several 
gene variants seem to be more strongly associated 
 
Replication Study 1 Replication Study 2 Replication Study 3 All Studies Combined
P Value
Odds Ratio 
(95% CI) P Value
Odds Ratio 
(95% CI) P Value
Odds Ratio 
(95% CI) P Value
Odds Ratio 
(95% CI)
8.81×10−22 0.64 (0.59–0.71) 3.29×10−1 0.85 (0.65–1.12) 6.32×10−3 0.77 (0.64–0.93) 5.35×10−27 0.67 (0.62–0.72)
2.45×10−13 0.74 (0.68–0.80) 2.40×10−1 0.88 (0.69–1.11) 1.21×10−2 0.83 (0.71–0.96) 1.38×10−16 0.76 (0.71–0.81)
2.45×10−10 0.74 (0.68–0.81) 6.79×10−1 0.97 (0.74–1.26) 2.03×10−2 0.84 (0.72–0.98) 1.34×10−12 0.77 (0.72–0.83)
4.94×10−5 1.18 (1.09–1.27) 1.54×10−1 1.16 (0.92–1.47) 5.66×10−2 1.16 (1.00–1.34) 8.73×10−8 1.19 (1.12–1.27)
9.23×10−9 1.27 (1.17–1.37) 2.29×10−2 1.29 (1.02–1.63) 1.79×10−5 1.39 (1.19–1.61) 2.17×10−16 1.31 (1.23–1.40)
6.63×10−8 1.25 (1.15–1.35) 4.95×10−1 1.08 (0.85–1.37) 9.87×10−5 1.35 (1.16–1.57) 5.42×10−14 1.28 (1.20–1.37)
1.80×10−11 1.32 (1.21–1.43) 3.95×10−2 1.30 (1.02–1.66) 8.20×10−7 1.47 (1.26–1.71) 3.39×10−21 1.37 (1.28–1.46)
3.62×10−3 0.87 (0.79–0.95) 1.39×10−3 0.65 (0.50–0.85) 8.92×10−1 1.01 (0.86–1.18) 5.10×10−5 0.86 (0.80–0.92)
9.48×10−8 0.77 (0.70–0.85) 2.45×10−1 0.85 (0.64–1.15) 7.31×10−5 0.69 (0.57–0.83) 4.77×10−12 0.76 (0.70–0.82)
6.64×10−23 1.53 (1.40–1.67) 4.69×10−4 1.60 (1.22–2.09) 1.11×10−2 1.26 (1.05–1.51) 1.36×10−31 1.52 (1.41–1.63)
1.46×10−37 1.70 (1.57–1.85) 7.29×10−6 1.74 (1.36–2.22) 4.54×10−8 1.55 (1.32–1.82) 3.72×10−54 1.68 (1.57–1.80)
3.32×10−18 0.66 (0.60–0.72) 3.07×10−2 0.75 (0.57–0.98) 1.05×10−2 0.81 (0.69–0.95) 4.64×10−24 0.68 (0.63–0.74)
3.83×10−28 1.59 (1.47–1.73) 7.11×10−2 1.26 (0.97–1.63) 9.21×10−5 1.44 (1.20–1.72) 3.77×10−40 1.59 (1.49–1.71)
5.26×10−18 1.56 (1.41–1.73) 1.31×10−2 1.51 (1.09–2.10) 1.86×10−7 1.77 (1.42–2.19) 1.77×10−30 1.63 (1.50–1.77)
2.23×10−5 1.22 (1.11–1.33) 4.51×10−1 1.10 (0.82–1.47) 1.49×10−1 0.86 (0.70–1.06) 5.53×10−5 1.17 (1.09–1.26)
8.16×10−5 1.20 (1.10–1.32) 5.59×10−1 1.07 (0.79–1.44) 1.13×10−1 0.84 (0.68–1.04) 2.52×10−4 1.16 (1.07–1.25)
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with the multibacillary form of the disease than 
the paucibacillary form, and our data indicate an 
association between variants at the LRRK2 locus 
and the multibacillary form only. Our results are 
consistent with those of the two-step model for 
the development of leprosy, in which successful 
infection of M. leprae is first established in ge-
netically predisposed persons, and the subsequent 
clinical manifestation of disease is influenced by 
other host factors and environmental factors.19 
Genomewide association studies that directly test 
for a genetic association with the multibacillary 
or the paucibacillary form may uncover additional 
host genetic factors involved in the second step 
of disease development.
Variants of HLA genes, HLA-DRB1 in particular, 
have been associated with leprosy20; both pro-
tective and risk alleles have been described.21 We 
too observed an association with leprosy within 
the MHC region (SNP rs602875, next to HLA-
DRB1), although we did not observe an associa-
tion of the disease with other previously reported 
“risk” loci: PARK2–PACRG, LTA, and a locus on 
chromosome 10p13 (Tables 3 and 4 in the Sup-
plementary Appendix).14-16 The association of dis-
ease with the HLA-DR–DQ locus observed in this 
study is consistent with the previously identified 
association between leprosy and HLA-DRB1 and 
the fact that there is extensive linkage disequi-
librium within the MHC region.
HLA-DR molecules present M. leprae peptide 
antigens to CD4+ T cells, which allows the T cells 
to be activated. In leprosy, this process is thought 
to lead to the generation of Th1 cells, which pro-
duce interferon-γ, resulting in macrophage mat-
uration and the production of antimycobacterial 
molecules. Failure of this process is thought to 
be critical for susceptibility to leprosy and infec-
tion by other mycobacteria.22 Although HLA-DR 
is a well-established initiator of this process, the 
theoretical biologic network (as generated with 
the use of an unsupervised Ingenuity Pathways 
Analysis) (Fig. 2) suggests that interferon-γ may 
also be regulated by genes implicated in our 
analysis — NOD2, RIPK2, and TNFSF15 — and is 
consistent with the finding that persons with mu-
tant interferon-γ are susceptible to mycobacte-
rial infection.19
TNFSF15 is a tumor necrosis factor (TNF)–like 
molecule expressed in macrophages and T cells23; 
it binds a TNF-family receptor (expressed primar-
ily on T cells) that mediates the switch from Th1 
cells to Th2 cells.24,25 NOD2 is an intracellular 
sensing molecule that recognizes the bacterial-
cell-wall peptidoglycan and the muramyl dipep-
tides motif.26 It is expressed by macrophages and 
epithelial cells. Ligand bound to NOD2 initiates 
signaling, which is mediated by RIPK2 through 
a ubiquination process that involves the recruit-
ment of TAK1 (transforming growth factor 
β–activated kinase 1) and NEMO (nuclear factor-κB 
[NF-κB] essential modulator) to the NOD2–RIPK2 
complex27; IKb proteins (encoded by NFKBIA and 
NFKBIB [nuclear factor of kappa light polypeptide 
gene enhancer in B cells inhibitor alpha and beta, 
respectively]) becomes degraded, leading to the 
Table 3. Heterogeneity Analysis of the Five Single-Nucleotide Polymorphisms (SNPs) Found to Be Differentially Associated with Clinical 
Subtypes.*
SNP Chromosome Position Gene
Multibacillary Leprosy 
(N = 1768)
Paucibacillary Leprosy 
(N = 1959)
P Value for 
Heterogeneity†
P Value
Odds Ratio  
(95% CI) P Value
Odds Ratio 
(95% CI)
rs3764147 13 43355925 C13orf31 7.47×10−62 1.93 (1.79–2.09) 5.11×10−21 1.44 (1.33–1.55) 5.44×10−10
rs10507522 13 43377000 C13orf31 2.99×10−28 0.60 (0.54–0.65) 9.40×10−10 0.77 (0.71–0.84) 2.57×10−6
rs9302752 16 49276604 NOD2 8.87×10−41 1.73 (1.60–1.88) 1.44×10−19 1.44 (1.33–1.55) 3.98×10−5
rs42490 8 90847650 RIPK2 1.35×10−19 0.69 (0.64–0.75) 9.54×10−8 0.82 (0.76–0.88) 8.23×10−4
rs1491938 12 38931897 LRRK2 2.26×10−6 0.81 (0.75–0.89) 2.96×10−1 0.96 (0.88–1.04) 8.55×10−4
* C13orf31 denotes the gene encoding chromosome 13 open reading frame 31, LRRK2 the gene encoding leucine-rich repeat kinase 2, NOD2 
the gene encoding nucleotide-binding oligomerization domain containing 2, RIPK2 the gene encoding receptor-interacting serine–threonine 
kinase 2, and SNP single-nucleotide polymorphism.
† P values were calculated on the basis of the difference in the odds ratios for the development of multibacillary leprosy and for the develop-
ment of paucibacillary leprosy.
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movement of NF-κB to the nucleus and the sub-
sequent activation of NF-κB target genes,28 such 
as TNFSF15. Consistent with our data are the phe-
notypes of mice deficient in Nod2 and Ripk2. 
These mice are highly susceptible to infection with 
M. tuberculosis29 and Chlamydophila pneumoniae,30 re-
spectively, owing to a failure to produce inflam-
matory cytokines known to initiate the Th1-cell 
responses.31
PARK2 is implicated through our network 
analysis, and variants of PARK2 are reported to 
be associated with susceptibility to leprosy, al-
though we did not observe any such association 
in our analyses.15 PARK2 is an E3 ligase, thought 
to regulate innate immunity.32 We therefore hy-
pothesize that PARK2 participates in ubiquination-
mediated NOD2 signaling. Variants of both PARK2 
and LRRK2 are associated with susceptibility to 
Parkinson’s disease and interact directly. LRRK2 is 
thought to regulate the ligase activity of PARK2.33
Taken together, it seems that five of the genes 
directly implicated in our study feature in the 
NOD2-mediated regulatory node of innate immu-
nity. The functions of the other two implicated 
genes, CCDC122 and C13orf31, are as yet unknown.
Variants of NOD2 and TNFSF15 are associated 
with Crohn’s disease and are linked to altered pro-
duction of interleukin-10 and altered Th1–Th2 
switching.34-36 It is therefore all the more nota-
ble that leprosy and Crohn’s disease have com-
mon immunologic features, including a Th1-cell 
response with granuloma formation. Moreover, 
mycobacterial infection has been described as a 
risk factor for Crohn’s disease.37,38
In summary, our genomewide association study 
highlights variants of genes encoding proteins in-
volved in the innate immune response as risk fac-
tors for developing leprosy.
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Figure 2. A Gene-Interaction Network of Five Genes 
Conferring Susceptibility to Leprosy and Five Other 
Genes.
An Ingenuity Pathways Analysis of the seven suscepti-
bility genes identified a single, closely connected net-
work of interacting genes, including 5 of the 7 ge es 
implicated in the development of leprosy in the 
genomewide association study (highlighted in red) and 
30 additional genes. The network was unlikely to have 
been identified by chance (one-sided P = 1.00×10−15 by 
Fisher’s exact test). Solid lines between genes repre-
sent known direct molecular interactions, and dashed 
lines, known indirect molecular interactions. CARD6 
denotes caspase recruitment domain family member 
6, CARD9 caspase recruitment domain family member 
9, HLA-DRB1 major histocompatibility complex class II 
DR beta 1, LRRK2 leucine-rich repeat kinase 2, NF-κB 
nuclear factor κB, NOD2 nucleotide-binding oligomer-
ization domain containing 2, RIPK2 receptor-interact-
ing serine–threonine kinase 2, and TNFSF15 tumor ne-
crosis factor (ligand) superfamily member 15.
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